Latest news with #SandyKennedy
Yahoo
23-04-2025
- Business
- Yahoo
TrustPoint and Hexagon Selected by NAVAIR for $1.2M SBIR Phase II Contract
TrustPoint to Partner with Hexagon | NovAtel and Hexagon US Federal to Deliver and Demonstrate First-of-its-Kind C-band GNSS Receivers for US Naval Air Systems Command DULLES, Va., April 23, 2025--(BUSINESS WIRE)--TrustPoint, a leader in advanced Positioning, Navigation, and Timing (PNT) technologies, has been awarded a $1.2 million Small Business Innovation Research (SBIR) Phase II contract from the United States Navy's Naval Air Systems Command (NAVAIR). This landmark contract will fund the first-ever delivery and initial demonstration of TrustPoint's C-band GNSS service-enabled receivers to the U.S. government, in partnership with Hexagon | NovAtel and Hexagon US Federal, both part of Hexagon, a global leader in GNSS technologies and services. TrustPoint joins forces with Hexagon US Federal and NovAtel to execute this groundbreaking project. Together, they bring decades of experience in military-grade GNSS equipment and services. The partnership merges TrustPoint's pioneering C-band services with NovAtel's cutting-edge GNSS receiver technology, marking a pivotal step forward in the development of resilient PNT solutions for military applications. "We are thrilled to collaborate with TrustPoint on this transformative project," stated Sandy Kennedy, vice president of innovation at Hexagon's Autonomy & Positioning division. "By integrating TrustPoint's C-band GNSS services into our advanced anti-jam receivers, we can deliver unprecedented PNT resilience." TrustPoint's leadership further emphasized the strategic importance of this milestone. "This Phase II award highlights the importance of frequency-diverse, resilient PNT solutions for today's military operations," said Chris DeMay, TrustPoint's Founder and COO. "Our C-band APNT service offers GPS-independent capabilities that ensure mission continuity in contested environments. We're honored to partner with the U.S. Navy to deliver innovative solutions that enhance the resiliency of DON platforms." The award underscores the growing importance of frequency and orbital diversity in the future of navigation and timing. With Hexagon as a key partner, TrustPoint is well-positioned to address the DoD's evolving challenges, ensuring PNT reliability under increasingly complex operational conditions. About TrustPoint TrustPoint is developing a revolutionary commercial GPS service, leveraging their next-gen C-band LEO satellite constellation. The TrustPoint system has been developed from the ground up to achieve the high performance, security, and availability required for autonomous navigation, critical infrastructure, and national security. Learn more at About Hexagon Hexagon is the global leader in precision technologies at any scale. Our digital twins, robotics and AI solutions are transforming the industries that shape our reality. Hexagon (Nasdaq Stockholm: HEXA B) has approximately 24,500 employees in 50 countries and net sales of approximately 5.4bn EUR. Learn more at and follow us @HexagonAB. NovAtel, part of Hexagon, is a global technology leader, pioneering end-to-end solutions for assured positioning for land, sea, and air. NovAtel designs, manufactures and sells high-precision positioning technology developed for efficient and rapid integration. Its solutions are empowering intelligent positioning ecosystems in vital industries that depend on the ability to tackle the most complex challenges in the most demanding environments. Learn more at Hexagon US Federal is a FOCI-mitigated and security cleared, independent subsidiary of Hexagon exclusively focused on bringing the broad range of Hexagon technologies to the US Federal government. With a diverse portfolio of personnel, facilities, and laboratories, Hexagon US Federal develops mission-specific solutions to our Nation's most critical missions. Learn more at About NAVAIR NAVAIR provides full life-cycle support for naval aviation aircraft, weapons, and systems operated by sailors and marines. This support includes research, design, development, and systems engineering, as well as acquisition, testing, and evaluation of military aircraft and airborne weapon systems. View source version on Contacts For more information, please contact: Burcu Erkmenmedia@ Sign in to access your portfolio
Business Wire
23-04-2025
- Business
- Business Wire
TrustPoint and Hexagon Selected by NAVAIR for $1.2M SBIR Phase II Contract
DULLES, Va.--(BUSINESS WIRE)--TrustPoint, a leader in advanced Positioning, Navigation, and Timing (PNT) technologies, has been awarded a $1.2 million Small Business Innovation Research (SBIR) Phase II contract from the United States Navy's Naval Air Systems Command (NAVAIR). This landmark contract will fund the first-ever delivery and initial demonstration of TrustPoint's C-band GNSS service-enabled receivers to the U.S. government, in partnership with Hexagon | NovAtel and Hexagon US Federal, both part of Hexagon, a global leader in GNSS technologies and services. 'By integrating TrustPoint's C-band GNSS services into our advanced anti-jam receivers, we can deliver unprecedented PNT resilience.' - Sandy Kennedy, vice president of innovation at Hexagon's Autonomy & Positioning division Share TrustPoint joins forces with Hexagon US Federal and NovAtel to execute this groundbreaking project. Together, they bring decades of experience in military-grade GNSS equipment and services. The partnership merges TrustPoint's pioneering C-band services with NovAtel's cutting-edge GNSS receiver technology, marking a pivotal step forward in the development of resilient PNT solutions for military applications. 'We are thrilled to collaborate with TrustPoint on this transformative project,' stated Sandy Kennedy, vice president of innovation at Hexagon's Autonomy & Positioning division. 'By integrating TrustPoint's C-band GNSS services into our advanced anti-jam receivers, we can deliver unprecedented PNT resilience.' TrustPoint's leadership further emphasized the strategic importance of this milestone. "This Phase II award highlights the importance of frequency-diverse, resilient PNT solutions for today's military operations," said Chris DeMay, TrustPoint's Founder and COO. "Our C-band APNT service offers GPS-independent capabilities that ensure mission continuity in contested environments. We're honored to partner with the U.S. Navy to deliver innovative solutions that enhance the resiliency of DON platforms." The award underscores the growing importance of frequency and orbital diversity in the future of navigation and timing. With Hexagon as a key partner, TrustPoint is well-positioned to address the DoD's evolving challenges, ensuring PNT reliability under increasingly complex operational conditions. About TrustPoint TrustPoint is developing a revolutionary commercial GPS service, leveraging their next-gen C-band LEO satellite constellation. The TrustPoint system has been developed from the ground up to achieve the high performance, security, and availability required for autonomous navigation, critical infrastructure, and national security. Learn more at About Hexagon Hexagon is the global leader in precision technologies at any scale. Our digital twins, robotics and AI solutions are transforming the industries that shape our reality. Hexagon (Nasdaq Stockholm: HEXA B) has approximately 24,500 employees in 50 countries and net sales of approximately 5.4bn EUR. Learn more at and follow us @HexagonAB. NovAtel, part of Hexagon, is a global technology leader, pioneering end-to-end solutions for assured positioning for land, sea, and air. NovAtel designs, manufactures and sells high-precision positioning technology developed for efficient and rapid integration. Its solutions are empowering intelligent positioning ecosystems in vital industries that depend on the ability to tackle the most complex challenges in the most demanding environments. Learn more at Hexagon US Federal is a FOCI-mitigated and security cleared, independent subsidiary of Hexagon exclusively focused on bringing the broad range of Hexagon technologies to the US Federal government. With a diverse portfolio of personnel, facilities, and laboratories, Hexagon US Federal develops mission-specific solutions to our Nation's most critical missions. Learn more at About NAVAIR NAVAIR provides full life-cycle support for naval aviation aircraft, weapons, and systems operated by sailors and marines. This support includes research, design, development, and systems engineering, as well as acquisition, testing, and evaluation of military aircraft and airborne weapon systems.
Associated Press
03-03-2025
- Health
- Associated Press
TransCelerate BioPharma Publishes Resources to Accelerate Industry Adoption of Newly-Released ICH E6(R3) Guidelines
New tools support sponsors in operationalizing important new guidelines to advance clinical trial conduct worldwide PHILADELPHIA, March 3, 2025 /PRNewswire/ -- TransCelerate BioPharma (TransCelerate), a global nonprofit organization dedicated to improving the health of patients by accelerating and simplifying the clinical R&D process, today announced the release of 13 tools designed to assist pharma R&D sponsors and their ecosystem partners in adapting to the newly issued ICH E6(R3) Good Clinical Practice (GCP) guidelines. The new global guidelines, released in January by the International Council for Harmonization of Technical Requirements for Human Use (ICH), emphasize flexibility, efficiency, and data quality in the conduct of clinical trials. In anticipation of these new guidelines, TransCelerate assembled a team of experts to evaluate the guidance and develop tools to support adoption of ICH E6 (R3). The array of tools announced today covers six focus areas: risk proportionality, monitoring, trial design, risk management, investigators, and data governance. 'The new guidelines represent an important step forward in protecting the safety, rights, and well-being of trial participants, enhancing the reliability of clinical trial data, and encouraging innovative approaches to trial design and use of technology. They will guide sites, sponsors and their service providers around the world to embrace quality by design and to act in a way that's fit for purpose and proportionate to the associated risks. These tools are designed to help stakeholders interpret and apply the guidelines and associated concepts,' said David Nickerson, Head of Clinical Quality Management at EMD Serono, and executive sponsor of TransCelerate's ICH E6(R3) initiative. 'Innovation in clinical research is at the heart of TransCelerate's work, and we're pleased to facilitate adoption of these new guidelines.' As a critical part of this initiative, TransCelerate partnered with the Association of Clinical Research Organizations (ACRO) to co-develop the tools related to risk management and data governance. This collaboration highlights the importance of leveraging shared expertise in addressing key challenges and optimizing clinical trial operations. 'ACRO is proud to partner with TransCelerate in developing essential tools to facilitate the industry's shift to a more flexible, risk-proportionate, and innovative approach to clinical trials, as outlined in the new ICH E6(R3) guidelines,' said Sandy Kennedy, Chief Quality, Regulatory Affairs, & Sustainability Officer at Fortrea and Vice-Chair at ACRO. 'By leveraging our collective expertise, we're confident these resources will help sponsors, CROs, and investigator sites optimize clinical trial operations—ultimately accelerating the delivery of new therapies to patients worldwide.' The full suite of tools is available on TransCelerate's website. TransCelerate is seeking input on two additional tools—Data Life Cycle Framework (co-developed with ACRO) and Trial Design Start-Up—as part of a public review. TransCelerate invites interested stakeholders (including sites, CROs, sponsors, academics and clinical trial vendors) to provide their perspectives and comments on these tools here. TransCelerate will be hosting a webinar, Navigating ICH E6(R3): Tools & Resources for Understanding Changes and Supporting Adoption, from 9:00 to 10:30 a.m. EST on March 4, 2025, together with ACRO, to discuss the ICH E6(R3) guidelines and how sponsors can leverage newly developed tools to support implementation. For more information or to register, visit . About TransCelerate BioPharma Inc.
